Peripheral Neuropathy
Severe peripheral neuropathy is a qualifying condition in Georgia’s Medical Cannabis Patient Registry. A Georgia-licensed physician evaluates your diagnosis, symptom severity, and medical history before deciding whether to certify you. Burning, numbness, or chronic neuropathic pain alone does not automatically establish eligibility.
$100 · Private 15-minute phone consultation with a Georgia-licensed physician. GMMC serves adults age 18 and older throughout Georgia.
Book on Calendly. Our team sends an eVisit link for your telemedicine visit. Payment is collected through eVisit after your visit. If our physician determines that you do not qualify for medical cannabis certification, we will refund any consultation fee you paid. State card fees are separate.
This guide explains the difference between neuropathy symptoms, physician certification, and evidence about cannabis. A registry evaluation does not promise pain relief, repair nerve damage, or replace ongoing care.
Does Peripheral Neuropathy Qualify in Georgia?
The Georgia Department of Public Health’s current patient guidance lists peripheral neuropathy when its symptoms are diagnosed as severe. You may encounter older pages using “severe or end-stage” wording. Follow the current state guidance and the physician’s assessment rather than assuming an older description still controls.
The law allows fully licensed physicians whose principal practice location is in Georgia to certify patients. Certification depends on medical judgment. Booking an appointment, paying a fee, or reporting discomfort is not a guarantee of approval.
A complete diagnosis and discussion of how symptoms affect daily life help the physician understand your situation. There is no six-month failed-treatment requirement listed in DPH’s patient eligibility guidance. Do not delay evaluation merely because an online article suggests that arbitrary waiting period.
See our Georgia qualifying conditions guide for the wider program. GMMC provides consultations for adults only.
Understanding Peripheral Neuropathy and Neuropathic Pain
Peripheral neuropathy involves injury or dysfunction of nerves outside the brain and spinal cord. The peripheral nervous system carries information between the central nervous system and the rest of the body. People may experience numbness, tingling, burning, weakness, or pain even from a light touch.
Neuropathic pain refers to pain associated with damage or disease affecting the sensory nervous system. It differs from many other causes of chronic pain. A description such as “electric shocks in my feet” can be useful to a clinician, but it cannot establish the cause without evaluation.
Symptoms may affect walking, balance, work, rest, and everyday activities. Some people have spontaneous pain without an obvious trigger; others find clothing or bedding uncomfortable. The diagnosis, distribution, duration, and severity all matter during a medical review.
Diabetic Peripheral Neuropathy
Diabetic peripheral neuropathy is a form of nerve damage associated with diabetes. It often affects the feet and legs and may also involve the hands and arms. The National Institute of Diabetes and Digestive and Kidney Diseases describes burning, tingling, numbness, pain, and weakness among possible symptoms.
Loss of sensation can make foot injuries difficult to notice. Continue diabetes management, foot care, and scheduled medical examinations. A medical marijuana card does not replace those parts of your care plan.
Chemotherapy-Induced Peripheral Neuropathy and Other Causes
Peripheral neuropathy can be associated with chemotherapy, metabolic conditions, nutritional problems, and other causes. Idiopathic neuropathy means the cause has not been identified. HIV neuropathy and postsurgical neuropathic pain also appear in research discussions.
Tell your treating clinician about new or changing symptoms. If you receive chemotherapy or HIV treatment, keep your oncology or infectious-disease team involved in medication decisions. A cannabis evaluation is not a substitute for investigating a new medical problem.
The state’s peripheral neuropathy criterion concerns symptoms diagnosed as severe. The physician reviews your individual history rather than assuming every person with a particular underlying disease qualifies.
Symptoms to Describe During Your Consultation
Prepare a brief description of what you experience: where symptoms occur, how long they have been present, and how they affect daily function. Include burning, numbness, tingling, weakness, balance concerns, and pain that interrupts sleep if these apply to you.
Describe prior therapy honestly, including benefits and unwanted effects. Explain whether prescription medications helped, whether symptoms changed, and what your current clinicians recommend. Do not exaggerate severity or stop medicine to strengthen a certification application.
Medical Records for a Peripheral Neuropathy Evaluation
Available records may include the diagnosis, neurology or primary-care notes, relevant test results, medication history, and information about diabetes, chemotherapy, or other underlying conditions. The physician determines which documentation is needed.
A useful appointment checklist includes:
Your current medication list, including supplements and nonprescription products
Available records describing peripheral neuropathy and symptom severity
Previous treatment attempts and any side effects
Current identity and Georgia residency documentation
Questions about eligibility, safety, and the state process
These records also help doctors weigh potential benefits, risks, and whether this option is appropriate for your individual situation.
Ask the team how to submit medical documents securely. Do not send records, identification, or detailed symptoms through the public website contact form.
Medical Marijuana Research for Neuropathic Pain
Research has examined cannabis and cannabinoids for neuropathic pain, including diabetic neuropathy. Findings do not establish that every product helps every patient or that obtaining a card will improve symptoms.
A 2026 systematic review of diabetic peripheral neuropathy trials included four randomized controlled trials. Three reported a statistically significant difference in pain compared with placebo; one did not show superiority. Small studies, different formulations, and risk of bias limit firm conclusions about efficacy for many patients.
These results may support discussion with your clinician, but they do not provide a universal dose or prove long-term benefit. Study products and supervision can differ from products patients purchase. A statistically significant result does not necessarily mean a large or meaningful improvement for an individual.
Clinical trials may examine pain scores without establishing recovery of damaged nerves. Ask whether a study measured function, sleep quality, adverse effects, and treatment duration as well as pain relief. An analgesic benefit and a cure are different outcomes.
The Endocannabinoid System and Cannabinoid Receptors
The cannabis plant contains compounds called cannabinoids, including THC and CBD. Researchers study their effects on the endocannabinoid system and cannabinoid receptors involved in nervous-system signaling.
Those mechanisms help explain why scientists investigate pain signals and possible therapeutic effects. They do not, by themselves, prove that a commercial cannabis product will treat nerve damage. Claims about anti-inflammatory or neuroprotective activity need to be distinguished from demonstrated clinical outcomes.
THC can cause psychoactive effects. CBD and THC are not interchangeable, and a higher concentration does not automatically provide a better result. Discussion of receptors, the immune system, or laboratory findings should not be mistaken for individualized treatment advice.
Research on Inhaled Cannabis and Other Formulations
Some research uses inhaled cannabis, while other trials use oral or other formulations. Results from one route cannot automatically be applied to another. Product composition, exposure, participants, and follow-up vary.
Research involving spinal cord injury, HIV neuropathy, or postsurgical neuropathic pain is not automatically evidence for all forms of peripheral neuropathy. A relevant study should match the patient population and question being considered.
This page does not recommend smoking cannabis, identify a best strain, or give a THC dosing schedule. Discuss potential benefit and risks with your treating clinicians and follow current Georgia product rules.
Potential Risks, Psychoactive Effects, and Older Adults
Possible concerns with cannabis include dizziness, fatigue, sedation, anxiety, and cognitive impairment. Balance and attention matter for people who already have numbness or difficulty walking. Older adults may have additional concerns involving multiple medications and falls.
Tell the physician about your health history, including depression, anxiety, prior substance-use problems, or a history of psychosis. These topics help an individualized assessment; a website cannot determine whether use would be appropriate.
High doses are not evidence of better analgesic effects. Even a low dose may produce unwanted effects in some people. Do not copy a dose from a trial or change your prescription medications based on online content.
Avoid driving or other safety-sensitive activities while impaired. Ask your care team about medication interactions and how to respond to adverse effects before starting any new product.
Continue Your Existing Neuropathy Care
Your clinicians may discuss treatment directed at the underlying cause, symptom management, and ways to maintain function. Depending on the diagnosis, prescription medications such as gabapentin or certain antidepressants may be considered.
Certification does not mean that conventional medicine has failed or that cannabis should replace it. Continue care for diabetes, cancer, HIV, or other conditions that contribute to nerve damage, including toxic exposure such as heavy metals.
If considering cannabis, discuss realistic goals such as daily function or sleep rather than assuming complete relief. Keep track of symptoms and adverse effects so that your treating clinicians can assess whether an approach is helping. Do not discontinue opioids or other medicines without their guidance.
How to Get a Peripheral Neuropathy Medical Marijuana Card in Georgia
The consultation and the state registry are separate parts of the process:
Book your consultation: Select a Calendly appointment for a private 15-minute phone consultation. GMMC serves adults statewide.
Receive your eVisit link: Our team sends the link for your telemedicine visit. Ask about secure records and appointment arrangements when needed.
Attend the physician evaluation: The physician reviews your diagnosis, symptom severity, medical history, and eligibility. Approval is based on medical judgment.
Pay through eVisit after your visit: The consultation fee is $100. If our physician determines that you do not qualify, we will refund any consultation fee you paid.
Complete the state process if certified: The physician submits required information to the registry. DPH verifies the information and sends state payment instructions.
Receive your state card: Follow DPH delivery instructions and allow up to 10 business days after state payment processing.
A consultation is not an immediate card, a prescription for cannabis, or a product purchase. GMMC’s consultation fee is separate from the state card fee and any dispensary purchases.
Identity, Residency, and State Verification
DPH requires current identity and proof of Georgia residency. A current Georgia driver’s license or state-issued ID may satisfy the identity requirement. When the accepted ID does not show your current Georgia address, additional residency documentation is needed.
DPH lists documents such as a utility bill, phone bill, medical bill, or pay stub showing your full name and street address. Follow its current instructions for passports, military IDs, or other accepted identification.
State verification may require additional information. Respond to DPH requests and ensure your contact details and address are accurate. Booking a consultation does not bypass these requirements.
State Card Fees, Validity, and Annual Certification
The state card fee is $30, with a $3.75 service fee when using DPH’s online payment portal. These fees are separate from GMMC’s $100 consultation.
The Medical Cannabis Card is valid for five years. Annual physician certification is generally required, so card expiration and certification timing are different. Georgia law exempts patients with incurable or irreversible conditions from annual certification. Confirm whether this applies to your documented condition and registry record with your certifying physician or Georgia DPH. Review the certification exception and card renewal.
DPH describes UPS delivery with a signature required. Health department pickup applies in specified circumstances, including certain address arrangements; it is not the only route. Check current DPH instructions rather than relying on older Low THC Oil Registry articles.
Current Georgia Possession and Product Rules
DPH currently lists a possession limit of 12,000 milligrams of THC for registered patients and caregivers. A valid card does not authorize unrestricted cannabis possession or override federal law.
Use the Georgia Access to Medical Cannabis Commission for current product restrictions, licensed dispensaries, and questions about available formulations. Do not assume that a product sold elsewhere is permitted in Georgia.
Ask about oils, tinctures, capsules, topicals, and other formulations through official guidance and licensed dispensaries. Availability and rules can change.
A caregiver helping with scheduling is not automatically authorized to possess or administer medical cannabis. Separate caregiver registration requirements apply. See DPH’s patient and caregiver instructions.
Frequently Asked Questions
Does Any Peripheral Neuropathy Diagnosis Qualify?
No automatic approval applies. DPH lists peripheral neuropathy when symptoms are diagnosed as severe. A Georgia-licensed physician reviews the diagnosis and makes the certification decision.
Do I Need Six Months of Failed Treatment?
DPH’s current patient guidance does not list that waiting period for peripheral neuropathy. Bring your available history; the physician determines what records and assessment are needed.
Can Adults Book From Anywhere in Georgia?
GMMC serves adults age 18 and older statewide through a private phone consultation. Book on Calendly; our team sends your eVisit link.
What If I Do Not Qualify?
If our physician determines that you do not qualify for medical cannabis certification, we will refund any consultation fee you paid. This is a consultation service, with no merchandise to return.
Is There a Best Cannabis Strain or Dose for Neuropathy?
This page does not recommend a strain, THC-to-CBD ratio, or dose. Research does not establish one universal approach. Your health history, medication use, potential risks, and state rules need individualized consideration.
Will Cannabis Reverse Numbness or Repair Nerve Damage?
A registry card does not establish that cannabis will reverse nerve damage or restore sensation. Research about pain outcomes should not be interpreted as proof of nerve recovery.
Is a Consultation the Same as Ongoing Neuropathy Treatment?
No. The certification evaluation does not replace your neurologist, primary-care clinician, diabetes team, or other treating clinicians. Keep established care and follow-up appointments.
Book Your Peripheral Neuropathy Consultation
If you have diagnosed peripheral neuropathy and want to discuss Georgia medical cannabis eligibility, gather your available records and medication list, then book your adult consultation.
Private 15-minute phone consultation · $100 · Adults 18+ throughout Georgia.
Our team sends your eVisit link. Payment is collected through eVisit after your visit. If our physician determines that you do not qualify, we will refund any consultation fee you paid.
See pricing and fees, our consultation refund policy, and booking assistance.
This page provides general education, not personalized medical advice, diagnosis, or treatment.